Penta Valent Tbk. vs Charlie Hospital Semarang Tbk. — how do they compare? Penta Valent Tbk. trades at Rp332 (market cap 586.19B, 546.8K 24h volume), while Charlie Hospital Semarang Tbk. trades at Rp270 (market cap 742B, 29.45M 24h volume). The key difference: Charlie Hospital Semarang Tbk. is the larger of the two by market cap, and Charlie Hospital Semarang Tbk. is more actively traded (29.45M versus 546.8K). Which is the better fit depends on your goals.
| PEVE | RSCH | |
|---|---|---|
Market Cap | 586.19B | 742B |
Volume | 546.8K | 29.45M |
Lot | 5.47K | 294.49K |
Turnover | 182.46M | 8.14B |
Average Price | 333.68 | 276.35 |
Value | 182.46M | 8.14B |
Indicative Equilibrium Price | 332 | 270 |
Indicative Equilibrium Volume | 60 | 103 |
Trailing returns across standard periods
Latest headlines on both assets
PT Penta Valent Tbk (the Company) was established in 1968 in Jakarta, Indonesia under the name of CV Penta Valent, hereinafter, based on Notarial Deed No. 48 of Bebasa Daeng Lalo, S.H., dated August 16, 1972. The Company started its commercial operations in 1968. PT Tancorp Global Sentosa, a company incorporated in Indonesia, is the ultimate parent entity of the Company.
Read more on PEVE →PT Charlie Hospital Semarang, Tbk (the "Company") was established based on Deed No. 35 dated 11 February 2019, which was made before Notary Nur Hadi, SH, MKn, notary in Kendal Regency and has been approved by the Minister of Law and Human Rights of the Republic of Indonesia based on Decree No. AHU-0008598.AH.01.01. Year 2019 February 11, 2019. The company started its commercial operations on September 23, 2019.
Read more on RSCH →